In 1977, the Nobel Prize in Physiology or Medicine was awarded to Roger Guillemin and Andrew Schally for their discovery and synthesis of gonadotropin-releasing hormone (GnRH), a key regulator of ...

Novo Nordisk has introduced Wegovy, a once-weekly weight loss injection, in India. The drug aims to manage obesity and reduce ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...

Bone growth occurs through the proliferation of specialized cells of the cartilage tissue, known as chondrocytes, on either ...

Shiru is inviting partners to harness its AI-powered ingredient discovery platform to explore ingredients that naturally ...

As Americans embrace Ozempic and food-as-medicine innovations, a new startup has created a bioactive peptide to activate the ...

Danish pharma giant Novo Nordisk’s announcement comes months after launch of another top selling obesity drug Mounjaro in ...

Combining elements of four hormones into a single drug, researchers hope a next-generation weight loss drug will address not ...

Weight loss drugs like Ozempic and Wegovy are used by over 15 million adults in the U.S., or 4.5% of the population. Despite ...